CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- 4 Shares withheld for taxes EVP & Chief Technology Officer gave up 454 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Operations gave up 427 shares (to pay taxes)
- 4 Grant or award Director acquired 106.19 shares (grant or award)
- 4 Grant or award Director acquired 128.95 shares (grant or award)
- 4 Grant or award Director acquired 79.64 shares (grant or award)
- 4 Shares withheld for taxes EVP, Operations gave up 1,338 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Technology Officer gave up 1,433 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Human Resources gave up 365 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Business Development gave up 225 shares (to pay taxes)
- 4 Open-market sale SVP & CCO sold 1,237 shares at $323.73 ($400,451)
- 4 Shares withheld for taxes EVP & CFO gave up 1,433 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Gen. Counsel & Sec. gave up 1,257 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Global Commercial Ops gave up 1,593 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Finance & CAO gave up 68 shares (to pay taxes)
- 4 Shares withheld for taxes Chairman, CEO and President gave up 5,057 shares (to pay taxes)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
Page 4 of 161 · 3,201 filings